NAD+ Injections and NAD+ Therapy in Fishers, IN

NAD+ injections and NAD+ therapy deliver nicotinamide adenine dinucleotide, an essential coenzyme involved in cellular energy production, mitochondrial metabolism, DNA repair and cellular signaling.

NAD+ is often offered within peptide, integrative-medicine and healthy-aging programs. It is sometimes described online as “NAD+ peptide therapy,” although NAD+ is not chemically a peptide. It is a nucleotide-based coenzyme found within every living cell.

Patients may explore NAD+ therapy when seeking physician-guided support for energy, physical recovery, mental clarity, metabolic health or healthy-aging goals. Human intravenous research has demonstrated that administered NAD+ enters measurable metabolic pathways. Studies of NAD+ precursors have also reported favorable changes in circulating NAD-related metabolites, skeletal-muscle measurements, sleep and selected physical-function outcomes.

There is no FDA-approved NAD+ injection for fatigue, anti-aging, cognitive enhancement, addiction treatment or general wellness. A medical evaluation should determine whether NAD+ therapy is appropriate and whether intravenous, intramuscular or subcutaneous administration may be considered.

To learn more about NAD+ injections and NAD+ therapy in Fishers, IN, call (765) 259-0545 or contact Charles Turner MD online.

What Is NAD+?

NAD+ stands for nicotinamide adenine dinucleotide. It is a naturally occurring coenzyme that helps cells transfer energy and carry out important chemical reactions.

NAD exists primarily in two related forms:

• NAD+: The oxidized form that accepts electrons during metabolic reactions
• NADH: The reduced form that carries electrons to other cellular processes

The movement between NAD+ and NADH helps convert nutrients from food into energy that cells can use.

The body can produce NAD+ from several dietary and metabolic sources, including:

• Niacin, or vitamin B3
• Nicotinamide
• Nicotinamide riboside, or NR
• Nicotinamide mononucleotide, or NMN
• Tryptophan

NAD+ also serves as a substrate for enzymes involved in cellular maintenance, inflammatory signaling, stress responses and DNA repair.

Is NAD+ a Peptide?

No. NAD+ is not a peptide.

Peptides are short chains of amino acids. NAD+ is a nucleotide-based coenzyme composed of two nucleotides joined through phosphate groups.

The phrase NAD+ peptide therapy is sometimes used because NAD+ injections are offered by many of the same medical practices that provide peptide therapy. The term describes how the treatment is marketed or grouped within a wellness program rather than its chemical classification.

A medically accurate description is NAD+ therapy, NAD+ injection therapy or NAD+ infusion therapy.

How Does NAD+ Support Cellular Energy?

Cells require energy to maintain their structure, communicate, repair damage and perform specialized functions. NAD+ participates in several pathways that convert carbohydrates, fats and proteins into usable cellular energy.

These pathways include:

• Glycolysis
• The citric acid cycle
• Fatty-acid oxidation
• The mitochondrial electron-transport chain
• Oxidative phosphorylation

Within mitochondria, NADH transfers high-energy electrons into the electron-transport chain. This process supports production of adenosine triphosphate, commonly called ATP.

ATP serves as a primary energy source for:

• Muscle contraction
• Nerve signaling
• Cellular transport
• Protein synthesis
• Tissue maintenance
• Immune activity

This biological role has contributed to interest in NAD+ for energy and recovery. Increasing exposure to NAD+ does not guarantee that fatigue or low energy will improve, since these symptoms can have many causes.

NAD+ and Mitochondrial Function

Mitochondria are cellular structures responsible for producing much of the body's ATP. NAD+ and NADH are central to how mitochondria process nutrients and transfer electrons.

NAD+ homeostasis may be affected by:

• Metabolic stress
• Inflammation
• Illness
• Oxidative damage
• Cellular demand for DNA repair
• Dietary intake
• Medication use
• Differences among tissues

Research involving NAD+ precursors has demonstrated that NAD-related metabolites can be increased in human blood and skeletal muscle. The degree to which these biochemical changes improve symptoms or physical performance varies among studies.

Patients with a diagnosed mitochondrial disease require evaluation and treatment from an appropriately qualified specialist. NAD+ therapy should not replace established medical care for a genetic or acquired mitochondrial disorder.

NAD+ and Cellular Repair

NAD+ supports more than energy production. Several enzyme systems use NAD+ while responding to cellular stress or damage.

These include:

• PARP enzymes: Participate in detecting and repairing selected forms of DNA damage
• Sirtuins: Influence metabolism, stress responses and gene regulation
• CD38 and related enzymes: Participate in immune signaling and calcium-related cellular communication

Using NAD+ for these processes can change how much is available for other metabolic reactions. This has contributed to research into NAD+ homeostasis during aging, inflammation, illness and periods of increased cellular stress.

NAD+ also participates indirectly in antioxidant systems that help cells respond to oxidative stress. It should not be viewed as a replacement for adequate sleep, nutrition, physical activity or treatment of an underlying disease.

Why Are Patients Interested in NAD+ Therapy?

Patients may discuss NAD+ injections with a physician when seeking additional support related to:

• Low energy or persistent fatigue
• Physical recovery
• Mental clarity and concentration
• Healthy-aging goals
• Metabolic wellness
• Sleep and daily performance
• Exercise recovery
• Cellular and mitochondrial health
• Recovery following illness or periods of stress
• Support during a comprehensive addiction-recovery program

These concerns do not all have the same level of clinical evidence. A consultation should identify the patient's primary symptoms and determine whether another medical condition requires treatment first.

What Does Current NAD+ Research Show?

NAD+ research includes laboratory studies, animal models, human precursor trials and a smaller amount of direct intravenous NAD+ research.

The strongest human evidence currently demonstrates biochemical activity. Researchers have shown that direct NAD+ administration and NAD+ precursors can change measurable NAD-related metabolites.

Human Intravenous NAD+ Metabolism

A human pilot study evaluated a six-hour intravenous infusion containing approximately 750 mg of NAD+.

The study included eight participants who received NAD+ and three participants who received saline. Researchers measured NAD+ and related metabolites in plasma and urine during the infusion and for two hours afterward.

Favorable findings included:

• A significant increase in plasma NAD+ by the end of the six-hour infusion
• Plasma NAD+ remaining elevated two hours after the infusion ended
• Increases in plasma nicotinamide and other NAD-related metabolites
• Increased urinary excretion of NAD+ and methyl nicotinamide
• No observable adverse events in the NAD+ group during the study

The absence of a measurable early plasma increase suggested that infused NAD+ was being rapidly taken up, broken down or metabolized during the first part of the infusion.

This study confirmed that intravenous NAD+ enters human metabolic pathways. It did not evaluate whether treatment improves energy, cognition, physical performance, addiction outcomes or longevity.

Nicotinamide Riboside and Blood NAD+

Nicotinamide riboside is a vitamin B3-related precursor that cells can use to produce NAD+.

A randomized, double-blind crossover study involving healthy middle-aged and older adults reported that six weeks of oral nicotinamide riboside:

• Increased NAD+ metabolism
• Was generally well tolerated
• Produced favorable exploratory findings involving blood pressure and arterial stiffness

These findings demonstrate that human NAD+ metabolism can be influenced through precursor supplementation. They do not establish that an NAD+ injection will produce the same result.

NAD+ Metabolites in Skeletal Muscle

A placebo-controlled crossover study evaluated oral nicotinamide riboside in older men.

After 21 days, researchers reported:

• Increases in the skeletal-muscle NAD+ metabolome
• Changes in NAD-related breakdown products
• Transcriptomic changes associated with inflammatory signaling
• Reduced concentrations of selected circulating inflammatory cytokines

The study provided evidence that NAD+ precursor therapy can influence human skeletal-muscle biology. It did not demonstrate a consistent improvement in mitochondrial energy production or physical performance.

NMN, Walking Speed and Sleep

A randomized, double-blind and placebo-controlled study evaluated 12 weeks of oral nicotinamide mononucleotide in older adults.

The NMN group experienced:

• Higher blood NAD+ and NAD-related metabolite levels
• A shorter four-meter walking time
• Maintenance of walking speed
• Improved sleep-quality measurements
• No adverse effects attributed to the study product

These findings involved oral NMN rather than direct NAD+ injection therapy. They support continued research into NAD+ metabolism and healthy-aging outcomes.

Comparison of NAD+ Precursors

A randomized human study directly compared nicotinamide, nicotinamide riboside and nicotinamide mononucleotide.

After 14 days, both NR and NMN significantly increased circulating NAD+ concentrations. Nicotinamide did not produce the same effect under the study conditions.

This research demonstrates that different NAD-related compounds are not interchangeable. Their absorption, metabolism and effects on blood measurements can differ.

Direct NAD+ vs. NAD+ Precursors

Direct NAD+ therapy and NAD+ precursor therapy are related but different approaches.

Substance	What It Is	How It Relates to NAD+
NAD+	The oxidized form of nicotinamide adenine dinucleotide	Administered directly through an infusion or injection
NADH	The reduced, electron-carrying form	Cycles with NAD+ during cellular-energy reactions
Nicotinamide riboside	A vitamin B3-related compound	Serves as a precursor that cells can convert into NAD+
Nicotinamide mononucleotide	An intermediate in NAD+ biosynthesis	Can be converted into NAD+ through cellular pathways
Nicotinamide	A form of vitamin B3	Can enter a salvage pathway used to produce NAD+

Results involving NR or NMN should not automatically be attributed to direct NAD+ injections. Each substance has different pharmacology, metabolism and clinical research.

NAD+ Injections vs. NAD+ IV Infusions

NAD+ may be discussed through several administration methods. The term “NAD+ injection” may refer to intramuscular, subcutaneous or intravenous administration.

Method	How It Is Administered	Important Considerations
Intravenous infusion	NAD+ is diluted in fluid and delivered gradually into a vein	Allows clinical monitoring and rate adjustment; has the most direct published human metabolism data
Intramuscular injection	NAD+ is injected into muscle tissue	Requires a shorter visit, but published human pharmacokinetic and outcomes data remain limited
Subcutaneous injection	NAD+ is injected into fatty tissue beneath the skin	May be used in smaller volumes; standardized human dosing and outcome data are limited
Oral precursor therapy	NR, NMN, nicotinamide or another precursor is taken orally	Does not deliver NAD+ directly but has a larger body of human biochemical research

Your physician should explain why a particular administration method is being considered and how it relates to your treatment goal.

NAD+ IV Therapy

During NAD+ IV therapy , NAD+ is diluted in sterile fluid and administered gradually through a vein.

The infusion rate may be adjusted according to patient comfort. Some people experience symptoms when the infusion runs too quickly, including nausea, abdominal pressure, flushing, chest pressure or an increased heart rate.

Slowing or temporarily pausing the infusion may reduce these symptoms. Intravenous treatment should be supervised by qualified medical personnel who can monitor the patient and respond to unexpected reactions.

The total appointment time depends on the dose, concentration and individual tolerance. NAD+ infusions may require more time than other wellness infusions because rapid administration can be uncomfortable.

Intramuscular NAD+ Injections

An intramuscular NAD+ injection delivers the preparation into a muscle, commonly in the upper arm, thigh or gluteal region.

Potential advantages may include:

• A shorter appointment than an intravenous infusion
• No need to maintain intravenous access
• Administration during a regular office visit
• The ability to use smaller treatment volumes

Human studies have not established that intramuscular NAD+ produces the same exposure, metabolic response or clinical outcomes as a prolonged intravenous infusion.

Possible injection-site effects include soreness, redness, swelling, bruising or temporary muscle discomfort.

Subcutaneous NAD+ Injections

A subcutaneous injection delivers NAD+ into tissue beneath the skin. This route may be discussed for lower-volume administration or a physician-supervised home-treatment plan.

Published human evidence specific to repeated subcutaneous NAD+ remains limited. A prescription should clearly state:

• The exact concentration
• The amount administered with each dose
• The injection frequency
• The appropriate injection sites
• How injection sites should be rotated
• How the product should be stored
• When follow-up is required

Patients should not copy NAD+ injection schedules found on social media, online forums or product-vendor websites.

NAD+ Therapy for Energy and Fatigue

NAD+ is essential to cellular-energy production, which has generated interest among patients experiencing low energy, reduced stamina or prolonged recovery.

Fatigue can also result from:

• Anemia or iron deficiency
• Thyroid dysfunction
• Vitamin B12 or folate deficiency
• Poor sleep or sleep apnea
• Depression or chronic stress
• Medication effects
• Viral or inflammatory illness
• Diabetes or metabolic disease
• Heart, lung, liver or kidney disease
• Inadequate nutrition or calorie intake

Patients experiencing persistent chronic fatigue should receive an appropriate medical evaluation. NAD+ therapy should not be used to mask a symptom that requires diagnosis.

NAD+ Therapy for Healthy-Aging Goals

NAD+ participates in cellular metabolism, stress-response signaling and DNA-repair pathways. These functions have made NAD+ a frequent focus of age-management and longevity research.

Research on age-related NAD+ changes in people is more complex than it is sometimes presented. NAD+ concentrations differ among tissues, and whole-blood levels may not decline uniformly with age.

NAD+ therapy has not been proven to:

• Reverse biological aging
• Extend human lifespan
• Prevent every age-related disease
• Restore youthful energy in every patient
• Replace preventive medical care

A healthy-aging plan should also address:

• Blood pressure and cardiovascular risk
• Glucose regulation
• Body composition and muscle strength
• Sleep quality
• Nutrition
• Physical activity
• Cognitive and emotional health
• Age-appropriate screening

NAD+ Therapy for Brain Health and Mental Clarity

The brain requires substantial cellular energy and uses NAD+ for neuronal metabolism, stress responses and DNA repair.

Patients may explore NAD+ therapy for concerns such as:

• Brain fog
• Reduced concentration
• Mental fatigue
• Slower processing
• Reduced daily productivity
• Healthy cognitive aging

These symptoms can also be associated with sleep loss, depression, anxiety, medications, hormone changes, nutritional deficiencies, concussion or a neurological condition.

A physician-guided brain-health evaluation can help determine whether additional testing is appropriate.

NAD+ injections are not established treatments for Alzheimer's disease, Parkinson's disease, dementia or another neurodegenerative condition.

NAD+ Therapy for Exercise and Physical Recovery

NAD+ is involved in skeletal-muscle metabolism and mitochondrial energy production. Studies involving NAD+ precursors have demonstrated measurable changes within human skeletal muscle.

Patients may discuss NAD+ therapy when experiencing:

• Reduced exercise tolerance
• Slower recovery between workouts
• Persistent physical fatigue
• Difficulty returning to activity after illness
• Changes in stamina associated with aging

Direct NAD+ injection research has not established that treatment:

• Builds muscle
• Improves athletic performance
• Increases aerobic capacity
• Prevents overtraining
• Repairs a sports injury

Exercise programming, nutrition, hydration, sleep and treatment of medical conditions remain central to physical recovery.

NAD+ Therapy and Metabolic Health

NAD+ participates in glucose metabolism, fat metabolism and cellular responses to nutrient availability.

Human precursor studies have reported favorable findings involving selected metabolic measurements, but results have varied according to the population, compound and outcome studied.

NAD+ injections should not replace established treatment for:

• Diabetes
• Insulin resistance
• High cholesterol
• Obesity
• Fatty liver disease
• Cardiovascular disease

A physician may incorporate NAD+ into a broader plan that includes nutrition, physical activity, medication, weight management and ongoing laboratory monitoring.

NAD+ Therapy and Addiction Recovery

Some treatment centers provide intravenous NAD+ during recovery from alcohol, opioid or other substance use.

Potential goals may include supporting hydration, nutrition, energy and patient comfort during a comprehensive recovery program. High-quality clinical trials have not established NAD+ as a stand-alone treatment for withdrawal, cravings or substance-use disorder.

Patients considering IV NAD+ for addiction treatment should receive evidence-based medical and behavioral care. Appropriate treatment may include:

• Medically supervised withdrawal management
• Medication for alcohol or opioid-use disorder
• Counseling and behavioral therapy
• Peer and family support
• Management of coexisting mental-health conditions
• Long-term relapse-prevention planning

NAD+ therapy should not replace emergency treatment or approved medications used to reduce overdose and relapse risk.

NAD+ Therapy vs. Vitamin B Injections

NAD+ is produced through pathways that use vitamin B3-related compounds, but NAD+ injections are not the same as vitamin B-complex injections .

Vitamin B injections supply one or more vitamins that may be used in many metabolic pathways. NAD+ therapy supplies the coenzyme itself.

The appropriate treatment depends on whether the patient has:

• A documented vitamin deficiency
• A dietary or absorption concern
• A medication-related nutrient depletion
• A specific NAD+ therapy goal
• Another medical cause of fatigue or neurological symptoms

A vitamin deficiency should be treated directly rather than assuming NAD+ therapy will correct it.

Who May Be Considered for NAD+ Therapy?

A physician may discuss NAD+ injections with an adult who has completed an appropriate health evaluation, understands the limitations of current evidence and has clearly defined treatment goals.

Potential candidates may include adults seeking physician-guided support for:

• Energy and wellness goals
• Physical or cognitive recovery
• Healthy-aging programs
• Metabolic and lifestyle optimization
• A structured integrative-medicine plan

A consultation does not mean that NAD+ therapy will automatically be recommended. Laboratory testing or medical history may identify another treatment with stronger evidence for the patient's symptoms.

Current Status of NAD+ Injections

There is no FDA-approved injectable NAD+ medication for anti-aging, fatigue, cognitive enhancement, exercise recovery, addiction treatment or general wellness.

There is also no FDA-approved:

• Wellness indication
• Intravenous dose or infusion rate
• Intramuscular dose
• Subcutaneous dose
• Treatment frequency
• Treatment duration
• Clinical monitoring standard

Some practices prescribe compounded NAD+ injections. Compounded medications do not undergo the same FDA premarket review for safety, effectiveness, quality and labeling as approved medications.

Because NAD+ injections must be sterile, ingredient suitability, preparation methods, testing, storage and handling are important.

Physician-Guided NAD+ Evaluation

A consultation should begin with your symptoms, medical history and goals rather than with a predetermined injection schedule.

Your physician may review:

• The type and duration of your symptoms
• Energy, sleep and physical-activity patterns
• Medical and surgical history
• Current medications and supplements
• Nutrition and alcohol use
• Previous vitamin, IV or peptide therapy
• Cardiovascular health
• Glucose and metabolic health
• Liver and kidney function
• Neurological or mental-health concerns
• Your expectations for treatment

Testing Before NAD+ Injection Therapy

There is no single blood test that determines whether every patient needs NAD+ therapy.

Depending on your symptoms and health history, your physician may recommend:

• Complete blood count
• Comprehensive metabolic panel
• Liver and kidney function
• Fasting glucose or hemoglobin A1c
• Thyroid testing
• Vitamin B12 and folate
• Iron and ferritin
• Lipid profile
• Inflammatory measurements when appropriate
• Additional blood testing based on your symptoms

Commercial NAD+ blood testing is available, but a single blood measurement may not accurately represent NAD+ concentrations within muscle, brain, liver or other tissues.

NAD+ testing is not a validated stand-alone measurement of biological age, longevity or treatment need.

How Is NAD+ Therapy Administered?

The administration plan depends on the formulation, treatment goal, medical history and clinical setting.

Possible approaches include:

• A slow intravenous infusion administered in a medical office
• An intramuscular injection administered by a clinician
• A subcutaneous injection administered in a clinic
• A physician-supervised subcutaneous home protocol

There is no standardized or FDA-approved NAD+ injection schedule. A protocol used by another patient or clinic should not be treated as a personalized recommendation.

Your prescribing clinician should explain:

• The exact formulation and concentration
• The proposed dose
• The administration route
• The expected appointment duration
• How the preparation should be stored
• How injections should be performed when applicable
• Which symptoms require medical attention
• How treatment response will be measured

What Does NAD+ Therapy Feel Like?

Patient experience varies according to the administration route, dose and infusion rate.

During intravenous treatment, some patients experience:

• Warmth or flushing
• Nausea
• Abdominal pressure or cramping
• Chest pressure
• Headache
• Dizziness
• An increased heart rate
• Temporary fatigue

These symptoms may improve when the infusion is slowed or paused. New chest pain, significant breathing difficulty, fainting or another severe reaction requires immediate medical assessment.

Intramuscular or subcutaneous injections may cause temporary:

• Injection-site pain
• Redness
• Swelling
• Bruising
• Itching
• Localized firmness

Important Treatment Considerations

NAD+ therapy should be prescribed and monitored according to the patient's health history and the route being used.

Important considerations include:

• Cardiovascular symptoms during rapid infusion
• Kidney and liver function
• Medication and supplement interactions
• Hydration status
• Blood-pressure or heart-rate changes
• Product identity, concentration and sterility
• Unknown effects of repeated long-term injections
• Limited human outcome data for wellness applications

Tell your physician if you:

• Are pregnant, planning pregnancy or breastfeeding
• Have significant heart, liver or kidney disease
• Have uncontrolled blood pressure
• Experience unexplained chest pain or palpitations
• Have active cancer or are receiving cancer treatment
• Take multiple prescription medications
• Have previously reacted to an IV infusion or injectable treatment

How Is Progress Monitored?

Measurable goals should be established before treatment begins.

Monitoring may include:

• Energy and fatigue ratings
• Sleep quality
• Concentration and mental clarity
• Exercise tolerance and physical recovery
• Ability to complete daily activities
• Blood pressure and heart rate
• Laboratory measurements based on medical need
• Infusion or injection reactions
• Changes in medications or health status
• Overall quality of life

Repeated NAD+ blood testing is not required for every patient and may not accurately measure changes within specific tissues.

Treatment should be reconsidered when measurable improvement does not occur, side effects develop or a patient's medical condition changes.

Frequently Asked Questions About NAD+ Injections

What is NAD+?

NAD+ is nicotinamide adenine dinucleotide, a coenzyme involved in cellular-energy production, mitochondrial metabolism, DNA repair and cellular signaling.

Is NAD+ a peptide?

No. NAD+ is a nucleotide-based coenzyme rather than a chain of amino acids. The phrase “NAD+ peptide therapy” is used because many clinics offer NAD+ alongside peptide treatments.

What are NAD+ injections used for?

NAD+ injections are commonly discussed for energy, recovery, cognitive wellness, healthy-aging and metabolic goals. These are not FDA-approved indications.

Do NAD+ injections increase energy?

NAD+ is essential to cellular-energy metabolism. Human research confirms biological activity, but clinical studies have not established that injections reliably increase energy in every patient.

What is the difference between NAD+ injections and NAD+ IV therapy?

NAD+ IV therapy delivers the preparation gradually through a vein. The term NAD+ injections may refer to intramuscular or subcutaneous administration. These routes differ in administration time, absorption and available human research.

Is NAD+ better by IV, intramuscular injection or subcutaneous injection?

No route has been established as best for every patient. Intravenous administration has the most direct human metabolism data. Published human evidence for intramuscular and subcutaneous NAD+ remains more limited.

How long does an NAD+ infusion take?

The appointment may last several hours depending on the dose and patient tolerance. NAD+ is often infused slowly because rapid administration may cause nausea, abdominal discomfort, flushing or chest pressure.

How quickly do NAD+ injections work?

There is no clinically validated timeline for changes in energy, cognition, recovery or healthy-aging measurements. Some patients report subjective changes sooner than others, while some may not experience a noticeable benefit.

Can NAD+ injections help brain fog?

NAD+ is involved in brain-cell metabolism, but injections have not been established as a treatment for brain fog. Persistent cognitive symptoms should be evaluated for sleep, medication, hormonal, nutritional, mental-health and neurological causes.

Can NAD+ therapy slow aging?

NAD+ participates in several pathways associated with cellular maintenance and stress responses. Human research has not established that NAD+ injections reverse aging or extend lifespan.

Can NAD+ injections help with weight loss?

NAD+ participates in metabolic pathways, but it is not an FDA-approved weight-loss medication. Nutrition, physical activity and evidence-based medical weight management remain necessary.

Can NAD+ therapy treat addiction?

NAD+ is offered by some addiction-recovery programs, but high-quality studies have not established it as a stand-alone treatment for substance-use disorder, withdrawal or cravings. It should only be considered as a possible adjunct to evidence-based addiction care.

Is NAD+ the same as NADH?

No. NAD+ is the oxidized form that accepts electrons. NADH is the reduced form that carries those electrons during energy-producing reactions.

Is NAD+ the same as NR or NMN?

No. Nicotinamide riboside and nicotinamide mononucleotide are precursors that the body can use to produce NAD+. They have different absorption and metabolic pathways.

Is NAD+ therapy FDA-approved?

No injectable NAD+ product is FDA-approved for anti-aging, fatigue, cognitive enhancement, exercise recovery, addiction treatment or general wellness.

Can NAD+ be combined with peptide therapy?

NAD+ may be offered alongside peptide or hormone treatment, but each therapy should have a clear medical purpose and monitoring plan. Combining treatments has not been established as more effective for every patient.

Can NAD+ be combined with vitamin injections or other IV treatments?

Some practices include NAD+ within broader wellness programs. Compatibility, concentration, stability and administration timing should be reviewed by the prescribing clinician and pharmacist rather than assumed.

What are the possible side effects of NAD+ injections?

Possible effects include nausea, abdominal discomfort, flushing, headache, dizziness, chest pressure, increased heart rate and injection-site reactions. Symptoms may depend on the dose, route and infusion rate.

Who may not be a candidate for NAD+ therapy?

Careful evaluation is appropriate for patients who are pregnant or breastfeeding, have significant cardiovascular, liver or kidney disease, experience unexplained chest symptoms, have active cancer or take medications that may affect treatment safety.

Explore NAD+ Injections and NAD+ Therapy in Fishers, IN

If low energy, slow recovery or healthy-aging concerns are affecting your daily life, a physician-guided consultation can help identify possible causes and appropriate treatment options.

Your physician can review your medical history, medications, laboratory results, symptoms and goals before discussing NAD+ injections or another approach.

Call (765) 259-0545 or contact Charles Turner MD online to request your consultation.

Medical References

• Human Plasma and Urine NAD+ Metabolism During a Six-Hour Intravenous NAD+ Infusion
• Chronic Nicotinamide Riboside Supplementation Is Well Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults
• Nicotinamide Riboside Augments the Aged Human Skeletal-Muscle NAD+ Metabolome and Induces Anti-Inflammatory Signatures
• Nicotinamide Mononucleotide Increased Blood NAD+, Maintained Walking Speed and Improved Sleep Quality in Older Adults
• Nicotinamide Riboside and Nicotinamide Mononucleotide Increase Circulating NAD+ in Healthy Adults
• Nicotinamide and D-Ribose Increase the NAD+ Metabolome and High-Energy Phosphates in Healthy Middle-Aged Adults